Terms: = Breast cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Diagnosis
362 results:
1. Differentiation of invasive ductal and lobular carcinoma of the breast using MRI radiomic features: a pilot study.
Maiti S; Nayak S; Hebbar KD; Pendem S
F1000Res; 2024; 13():91. PubMed ID: 38571894
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcome of 9G MRI-guided vacuum-assisted breast biopsy: results of 293 single-center procedures and underestimation rate of high-risk lesions over 12 years.
Rescinito G; Brunetti N; Garlaschi A; Tosto S; Gristina L; Conti B; Pieroni D; Calabrese M; Tagliafico AS
Radiol Med; 2024 May; 129(5):767-775. PubMed ID: 38512628
[TBL] [Abstract] [Full Text] [Related]
3. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience.
Bufman H; Faermann R; Halshtok-Neiman O; Shalmon A; Gotlieb M; Samoocha D; Yagil Y; Feldman DM; Friedman E; Sklair-Levy M
Breast Cancer Res Treat; 2024 Jun; 205(2):281-285. PubMed ID: 38379091
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer.
Cavaller L; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102740. PubMed ID: 38311000
[TBL] [Abstract] [Full Text] [Related]
6. [A Case of Triple Negative breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
7. The discriminatory diagnostic value of multimodal ultrasound combined with blood cell analysis for granulomatous lobular mastitis and invasive ductal carcinoma of the breast.
Zeng YH; Yang YP; Liu LJ; Xie J; Dai HX; Zhou HL; Huang X; Huang RL; Liu EQ; Deng YJ; Li HJ; Wu JJ; Zhang GL; Liao ML; Xu XH
Clin Hemorheol Microcirc; 2024; 86(4):481-493. PubMed ID: 38007642
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Yang X; Tang T; Zhou T
World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
[TBL] [Abstract] [Full Text] [Related]
9. Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).
Antolín Novoa S; Escrivá-de-Romaní S; Tolosa Ortega P; Oliva Fernández L; López López R; López González A; de la Morena Barrio P; Echavarria Díaz-Guardamino I; Alés Martinez JE; Garate Z; González-Cortijo L
Cancer Treat Res Commun; 2023; 37():100772. PubMed ID: 37995519
[TBL] [Abstract] [Full Text] [Related]
10. Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma.
Yoon TI; Jeong J; Lee S; Ryu JM; Lee YJ; Lee JY; Hwang KT; Kim H; Kim S; Lee SB; Ko BS; Lee JW; Son BH; Metzger O; Kim HJ
JAMA Netw Open; 2023 Nov; 6(11):e2342270. PubMed ID: 37938845
[TBL] [Abstract] [Full Text] [Related]
11. Nonlobular Invasive breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
[TBL] [Abstract] [Full Text] [Related]
12. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract] [Full Text] [Related]
13. Investigation of the miR-637 and miR-523-5p as candidate biomarkers in breast cancer.
Coskunpinar E; Tiryakioglu DZ; Abaci N; Tukenmez M; Pence S
Bratisl Lek Listy; 2023; 124(11):814-820. PubMed ID: 37874803
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of breast cytoarchitecture and its associated axillary lymph node status under normal and pathological conditions in Egyptian women.
Mansour O; Kazem A; El Wakil A
Tissue Cell; 2023 Dec; 85():102244. PubMed ID: 37856936
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and Imaging Features of MRI Screen-Detected breast cancer.
Ghuman N; Ambinder EB; Oluyemi ET; Sutton E; Myers KS
Clin Breast Cancer; 2024 Jan; 24(1):45-52. PubMed ID: 37821332
[TBL] [Abstract] [Full Text] [Related]
16. Metaplastic breast carcinoma: Analysis of clinical and pathologic features, a five-year study.
Chaudhary D; Balhara K; Mandal S; Mallya V; Tomar R; Khurana N; Bains L
J Cancer Res Ther; 2023; 19(5):1226-1230. PubMed ID: 37787287
[TBL] [Abstract] [Full Text] [Related]
17. Unveiling bone metastasis: Exploring histological subtypes of breast cancer in Indonesia's tertiary referral hospital.
Siregar KB; Al Anas M
Cancer Treat Res Commun; 2023; 37():100764. PubMed ID: 37769530
[TBL] [Abstract] [Full Text] [Related]
18. Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging.
Chen H; Li X; Li F; Li Y; Chen F; Zhang L; Ye F; Gong M; Bu H
J Pathol; 2023 Oct; 261(2):125-138. PubMed ID: 37555360
[TBL] [Abstract] [Full Text] [Related]
19. Fiber optic probe-based ATR-FTIR spectroscopy for rapid breast cancer detection: A pilot study.
Zhang S; Vasudevan S; Tan SPH; Olivo M
J Biophotonics; 2023 Nov; 16(11):e202300199. PubMed ID: 37496212
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ.
Liu Y; Yu T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11181-11191. PubMed ID: 37354223
[TBL] [Abstract] [Full Text] [Related]
[Next]
